GW Pharmaceuticals Is Picking Up Steam in 2020
If you had given up on marijuana stocks, let me tell you why you should reconsider this year. Cambridge, U.K.-based GW Pharmaceuticals' (NASDAQ: GWPH) stock suffered with its peers in the past year's sell-off, but the recent surge in pot sales drove impressive first-quarter results. GW Pharmaceuticals is the maker of Epidiolex, a prescription drug containing cannabidiol, or CBD, for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome.